• L2D has been granted Crédit d’Impôt Recherche (CIR) accreditation (2010-2012). CIR
• L2D opens new offices in London and Lyon.
• L2D has been granted SME status by the EMEA (Feb. 25, 2010).
•"In drug development not all projects are companies", Pharma mag.
•"Leads To Development", La Gazette du Laboratoire.
•"From bench to bedside: a new preclinical development strategy", SP2.
•"About L2D's non-clinical development solutions", Biotech Intelligence . editorial
•"Most biotechs will be virtual in 25 years...", Outsourcing Pharma. article
CLARA 2011…
4ème Rencontre Industriels-Académiques du CLARA
Genesis 2011…
The leading biotechnology networking conference
Rare 2011…
Eurobiomed meeting on rare diseases
BIO-Europe 2011…
17th annual conference
BioPartnering Europe…
19th annual conference
Tech Transfer Summit Europe…
5th Annual TTS Europe
ECC Partnering…
Partnering Meeting of the European Cancer Cluster
BioTuesday Lyon…
Networking event at Lyon